H. L. Fairchild
YOU?
Author Swipe
View article: Targeting Semaphorin 7a signaling in preclinical models of estrogen receptor-positive breast cancer
Targeting Semaphorin 7a signaling in preclinical models of estrogen receptor-positive breast cancer Open
Estrogen receptor-positive (ER+) breast cancer (BC) comprises over 70% of breast cancers and is the leading cause of BC-related deaths in women worldwide. Despite available therapies targeting ER in BC, recurrence occurs in many patients d…